KRYSTAL BIOTECH INC
KRYSTAL BIOTECH INC
Share · US5011471027 · KRYS · A2JH2F (XNMS)
Overview Financial Indicators
136,94 USD
3,17 % 4,21 USD
NASDAQ/NMS (GLOBAL MARKET) (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 19:59

Current Prices from KRYSTAL BIOTECH INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
KRYS
USD
06.06.2025 19:59
136,94 USD
132,73 USD
+3,17 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 8,72 % -1,81 % -23,47 % -26,08 % -17,35 % 189,39 %

Company Profile for KRYSTAL BIOTECH INC Share

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.

Invested Funds

The following funds have invested in: KRYSTAL BIOTECH INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
46,89
Percentage (%)
0,11 %

Company Data

Name KRYSTAL BIOTECH INC
Company Krystal Biotech, Inc.
Symbol KRYS
Website https://www.krystalbio.com
Primary Exchange XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A2JH2F
ISIN US5011471027
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Krish S. Krishnan M.B.A., M.S.
Market Capitalization 5 Mrd.
Country United States of America
Currency USD
Employees 0,3 T
Address 2100 Wharton Street, 15203 Pittsburgh
IPO Date 2017-09-20

Ticker Symbols

Name Symbol
Frankfurt 4KB.F
NASDAQ KRYS

More Shares

Investors who KRYSTAL BIOTECH INC hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
BITTORRENT
BITTORRENT Crypto
CINTAS CORP
CINTAS CORP Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
DEXCO INC
DEXCO INC Share
DOLLAR TREE INC
DOLLAR TREE INC Share
FISERV INC
FISERV INC Share
IDEXX LABORATORIES INC
IDEXX LABORATORIES INC Share
INTUIT INC
INTUIT INC Share
ISHSIV-MSCI CHINA DL A
ISHSIV-MSCI CHINA DL A ETF
LB.HESS.THR.CARRARA01H/22
LB.HESS.THR.CARRARA01H/22 Bond
UNITED BANCORPINC
UNITED BANCORPINC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025